Anika Therapeutics, Inc. (ANIK): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Anika Therapeutics (ANIK) shares rose 43.4% over the past 3 months, driven by optimism around its commercial products, pipeline progress, and improving financial outlook. The company reported strong Q2 2026 results with total revenues up 16% YoY, and raised its 2026 guidance. ANIK's pipeline includes Cingal and Hyalofast, with regulatory progress ongoing. The company adopted a conservative 2027 outlook, excluding unapproved products from forecasts.

Strategic Execution and Operational Drivers Achieved record commercial channel revenue growth of 17%, fueled by focused portfolio alignment and strong international demand for CINGAL and MONOVISC. Expanded gross margins to 65% by implementing a lean transformation that doubled throughput on key manufacturing lines and improved production yields.

Anika Therapeutics, Inc. (ANIK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Anika Reports Second Quarter 2026 Financial Results Commercial Channel Revenue Increased 17% to a Record $13.9 Million Delivered $3.3 Million of Net Income, 65% Gross Margin, and $7.1 Million of Adjusted EBITDA, Highest Since 2020 Raising Full-Year 2026 Financial Gui

HDFC Bank, India's largest private lender, announced CEO Sashidhar Jagdishan will step down in October, not seeking reappointment. This follows governance concerns, regulatory scrutiny, and a 27% stock decline since January. The bank's board previously penalized Jagdishan for business overreach. Investors have also been disappointed by lack of financial gains from the 2023 merger with HDFC Ltd.

Woodside Energy abandoned its long-term Scope 3 climate targets, including a US$5 billion clean-energy investment plan. The company reported a 7% rise in underlying net profit to US$1.33 billion and a 27% increase in statutory net profit to US$1.67 billion. Woodside's Senegalese field, Sangomar, is central to its strategy, with production averaging 99,000 barrels per day. The company is also in a tax arbitration with Senegal's government over a US$68 million reassessment.

A Brazilian court approved Braskem's out-of-court reorganization plan, shielding it from creditor claims. The plan covers $10.9B in unsecured debt and has a 90-day window for creditor support. Braskem's shares rose 3.55% on the news, but cash flow remains a constraint.